z-logo
Premium
The effect of the plasma levels of proteins C and S on the prediction of warfarin maintenance dose requirements
Author(s) -
Lubetsky Aharon,
Seligsohn Uri,
Ezra David,
Halkin Hillel
Publication year - 1992
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1038/clpt.1992.101
Subject(s) - warfarin , clinical pharmacology , medicine , prothrombin time , vitamin k , protein c , maintenance dose , pharmacology , atrial fibrillation
Objective : Determination of the effects of the vitamin K—dependent anticoagulants, proteins C and S, on warfarin dose requirements and on the prediction error of a bayesian warfarin dose predicting program. Methods : Patients in the study were consecutive inpatients ( n = 18) starting treatment with warfarin who were monitored as outpatients for 4 weeks. The following measurements were taken: repeated ( n = 8) prothrombin times, expressed as the international normalized ratio (INR), plasma protein C and S antigen levels (percentage of pooled normal plasma), demographic, clinical and biochemical variables. Results : Maintenance doses (adjusted to INR 2.5) were 6.7 ± 3.4 mg/day. Protein C decreased to 56.9% ± 15.3%, protein S to 63.7% ± 17.3%, INR increased to 2.46 ± 0.14. Prediction error decreased from 2.84 ± 2.0 mg/day to 0.95 ± 0.78 mg/day. Protein C accounted for only 4.2% of the mean maintenance dose but protein C and S levels accounted for 31% of the mean dose prediction error. Conclusion : Protein C and S levels affect warfarin doses and predictions significantly but not to a clinically meaningful degree. Clinical Pharmacology and Therapeutics (1992) 52, 42–49; doi: 10.1038/clpt.1992.101

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom